Insights that cut through complexity
Webinar On-Demand: Breaking Down the Hottest Topic in Pharmacy: Humira Biosimilars
Uncover what could happen with Humira and the biosimilar market in 2023 While biosimilars have existed for many years, the topic has been gaining some
Potent Veterinary Drug Resistant to Narcan and It’s Rising Illicit Use Among Humans – RemedyOne’s Rob Louie Quoted in an Insightful Analysis with Fox News
A Fox News article recently quoted RemedyOne EVP of clinical services Rob Louie on xylazine, a potent veterinary drug that has seen a recent uptick
Hemophilia Gene Therapies: Are the World’s Most Expensive Drugs Really Worth It?
Hemgenix became the most expensive drug in the history of FDA-approvals back in November of 2022 after the manufacturer, CSL Behring, hung a $3.5 million
What Is a Cough Medicine Doing in My Anti-depressant?
This might come as a surprise to some individuals as they dive into the listed ingredients of the newest FDA-approved anti-depressant to hit the market,
Whitepaper: Breaking Down the Hottest Topic in Pharmacy—Humira Biosimilars
The industry report you’ve been waiting for. Today biosimilars seem to be the topic of conversation everywhere. Why? Humira. The launch of Humira biosimilars will be
Unpacking the Biosimilar Buzz
As industry experts, it’s the number one topic we’re being asked to comment on. While biosimilars have existed for many years, the topic has been
Study Shows Talarozole May Help Osteoarthritis Patients
Healthline recently asked me to provide context for an article about recent research showing that talarozole may reduce and modify the symptoms of osteoarthritis, a
Competition is on the Horizon for Costly Narcolepsy Treatments
See this article by RemedyOne clinical pharmacist, Jason Peterson, R.Ph. as it originally appeared in Pharmaphorum. People who live with narcolepsy — about one out of every
It’s Been a Long Time Coming for Long-Term Topical Psoriasis Treatments
RemedyOne EVP of clinical services Robert Louie recently published an article for Pharmaphorum about topical psoriasis treatments Vtama and Zoryve. Below is an excerpt. Psoriasis
Relyvrio and the ALS Treatment Landscape
Amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig’s Disease, is a rare, progressive, neurodegenerative disorder that affects nerve cells in the spinal cord
Enhertu: The New Oncology ‘Smart Bomb’
An article on Health.com recently quoted me about an exciting new FDA-approved drug shown to extend metastatic breast cancer patients’ lives significantly. Enhertu is a
Recent months have brought new waves of viral infections across the globe, particularly, monkeypox. Scientists first identified monkeypox in Denmark in the late 1950s in
Mounjaro: Competing To Be the Best
Jason Peterson and RemedyOne EVP of clinical services Robert Louie have also written about Mounjaro for Pharmaphorum. Man o’ War, Seabiscuit, Secretariat, Seattle Slew, Trulicity,
Drug Treatment of Presbyopia: Medical Necessity or Convenience?
Some say things get better with age. Cheese, wine, and whiskey are a few examples that come to mind. Unfortunately, your vision is not one
Six Months After Authorization, What Do We Know About Paxlovid?
See this article by RemedyOne EVP of clinical services Robert Louie as it originally appeared in Pharmaphorum. It has now been over six months since
How the Pharmaceutical Industry Can Turn the Tide on Mental Health
May is Mental Health Awareness Month. RemedyOne president Ralph Pisano wrote this article for Fierce Healthcare about how the pharmaceutical industry can do more to